1. Home
  2. SUI vs INCY Comparison

SUI vs INCY Comparison

Compare SUI & INCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUI
  • INCY
  • Stock Information
  • Founded
  • SUI 1975
  • INCY 1991
  • Country
  • SUI United States
  • INCY United States
  • Employees
  • SUI N/A
  • INCY N/A
  • Industry
  • SUI Real Estate Investment Trusts
  • INCY Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • SUI Real Estate
  • INCY Health Care
  • Exchange
  • SUI Nasdaq
  • INCY Nasdaq
  • Market Cap
  • SUI 16.0B
  • INCY 13.0B
  • IPO Year
  • SUI 1993
  • INCY 1993
  • Fundamental
  • Price
  • SUI $126.81
  • INCY $77.73
  • Analyst Decision
  • SUI Buy
  • INCY Hold
  • Analyst Count
  • SUI 14
  • INCY 20
  • Target Price
  • SUI $137.57
  • INCY $77.69
  • AVG Volume (30 Days)
  • SUI 1.3M
  • INCY 1.6M
  • Earning Date
  • SUI 07-30-2025
  • INCY 07-29-2025
  • Dividend Yield
  • SUI 3.28%
  • INCY N/A
  • EPS Growth
  • SUI 1883.93
  • INCY 900.04
  • EPS
  • SUI 10.23
  • INCY 4.37
  • Revenue
  • SUI $3,217,100,000.00
  • INCY $4,584,996,000.00
  • Revenue This Year
  • SUI N/A
  • INCY $13.53
  • Revenue Next Year
  • SUI $3.48
  • INCY $10.38
  • P/E Ratio
  • SUI $12.40
  • INCY $17.79
  • Revenue Growth
  • SUI 17.94
  • INCY 18.87
  • 52 Week Low
  • SUI $109.22
  • INCY $53.56
  • 52 Week High
  • SUI $147.83
  • INCY $83.95
  • Technical
  • Relative Strength Index (RSI)
  • SUI 56.42
  • INCY 67.13
  • Support Level
  • SUI $115.53
  • INCY $73.81
  • Resistance Level
  • SUI $127.44
  • INCY $78.77
  • Average True Range (ATR)
  • SUI 3.05
  • INCY 2.03
  • MACD
  • SUI 0.42
  • INCY 0.76
  • Stochastic Oscillator
  • SUI 94.71
  • INCY 90.99

About SUI Sun Communities Inc.

Sun Communities is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently owns a portfolio of 645 properties, which includes 341 manufactured housing communities, 166 residential vehicle communities, and 138 marina properties. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Share on Social Networks: